Reach Us +1-218-451-2974


Advanced Glycation End Products And Autism- Evidence For A Connection | 12453
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per Google Scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Advanced glycation end products and autism- Evidence for a connection

International Conference on Psychology, Autism and Alzheimers Disease

Pamela Maher

ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.002

Autism is a complex and heterogeneous neurodevelopmental disorder of unknown etiology which results from both genetic and environmental factors. Among the environmental factors associated with autism are maternal obesity and diabetes. AGEs are a heterogeneous group of macromolecules that are formed by the non-enzymatic glycation of proteins, lipids and nucleic acids. AGEs are implicated in diabetic complications and can induce oxidative stress and inflammation. Humans are exposed to two sources of AGEs: exogenous AGEs that are ingested in foods and endogenous AGEs that are formed in the body. Diets with a high glycemic index are also associated with the accumulation of AGEs in the body. To test the hypothesis that AGEs contribute to the development of autism we used BTBR mice, a genetically homogeneous inbred strain of mice that displays behavioral traits that reflect all three diagnostic symptoms of autism including abnormal social interactions, impaired communication and repetitive behavior. Adult female mice were fed either a low or high glycemic diet beginning prior to impregnation. Their offspring were fed the same diet and at 10 weeks of age male mice were tested for behavioral markers of autism. We show that the BTBR mice continuously exposed to a low glycemic diet beginning at conception showed significant reductions in multiple, autism-associated behaviors including repetitive grooming and perseveration. Overall, these data suggest that AGEs, a major consequence of diabetes, can contribute to the development of an autistic phenotype and suggest that maternal dietary modifications could have an impact on the development of autism.
Pamela Maher obtained her Ph.D. in Biochemistry from the University of British Columbia followed by postdoctoral studies at the University of California, San Diego. Over the last 10 years her research has evolved from basic studies on the mechanisms underlying nerve cell survival and death to more translationally-oriented research on the development of approaches to prevent neurological disorders. She has over 100 publications in peer-reviewed journals. Her research is currently funded by NIH.